|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4468 | |
| A61P 25/00 |
| (11) | Patento numeris | 2200610 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08831500.7 |
| Europos patento paraiškos padavimo data | 2008-09-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-06-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/077139 |
| Data | 2008-09-19 |
| (87) | Numeris | WO 2009/039460 |
| Data | 2009-03-26 |
| (30) | Numeris | Data | Šalis |
| 974426 P | 2007-09-21 | US | |
| 986250 P | 2007-11-07 | US | |
| 50976 | 2008-05-06 | US |
| (72) |
HACKSELL, Uli, US
MCFARLAND, Krista, US
|
| (73) |
Acadia Pharmaceuticals Inc.,
3611 Valley Centre Drive, Suite 300, San Diego, CA 92130,
US
|
| (54) | CO-ADMINISTRATION OF PIMAVANSERIN WITH OTHER AGENTS |
| CO-ADMINISTRATION OF PIMAVANSERIN WITH OTHER AGENTS |